Evaluation of artemether-lumefantrine efficacy in the treatment of uncomplicated malaria and its association with pfmdr1, pfatpase6 and K13-propeller polymorphisms in Luanda, Angola

Polymorphisms in Plasmodium falciparum K13-Propeller in Angola and Mozambique after the Introduction of the ACTs

(2015) Carlos Escobar et al.   PLoS One

Polymorphisms in Plasmodium falciparum Chloroquine Resistance Transporter and Multidrug Resistance 1 Genes: Parasite Risk Factors That Affect Treatment Outcomes for P. falciparum Malaria After Artemether-Lumefantrine and Artesunate-Amodiaquine

(2014) Meera Venkatesan et al.   AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE

Efficacy of Artemether-Lumefantrine and Dihydroartemisinin-Piperaquine for Treatment of Uncomplicated Malaria in Children in Zaire and Uíge Provinces, Angola

(2014) Mateusz M. Plucinski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Comparative Impacts Over 5 Years of Artemisinin-Based Combination Therapies on Plasmodium falciparum Polymorphisms That Modulate Drug Sensitivity in Ugandan Children

(2014) Melissa D. Conrad et al.   JOURNAL OF INFECTIOUS DISEASES

K13-propeller mutations confer artemisinin resistance in Plasmodium falciparum clinical isolates

(2014) J. Straimer et al.   SCIENCE

Guideline: the laboratory diagnosis of malaria

(2013) J. Wendi Bailey et al.   BRITISH JOURNAL OF HAEMATOLOGY

A molecular marker of artemisinin-resistant Plasmodium falciparum malaria

(2013) Frédéric Ariey et al.   NATURE

Increasedpfmdr1copy number inPlasmodium falciparumisolates from Suriname

(2013) Mergiory Labadie-Bracho et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Variouspfcrtandpfmdr1Genotypes of Plasmodium falciparum Cocirculate with P. malariae, P. ovale spp., and P. vivax in Northern Angola

(2012) Cláudia Fançony et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Evolution of Plasmodium falciparum drug resistance: implications for the development and containment of artemisinin resistance

(2012) Toshihiro Mita et al.   JAPANESE JOURNAL OF INFECTIOUS DISEASES

Efficacy and tolerability of a new formulation of artesunate-mefloquine for the treatment of uncomplicated malaria in adult in Senegal: open randomized trial

(2012) Roger CK Tine et al.   MALARIA JOURNAL

Assessment of the therapeutic efficacy of artemether-lumefantrine in the treatment of uncomplicated Plasmodium falciparum malaria in northern KwaZulu-Natal: an observational cohort study

(2012) Charles H Vaughan-Williams et al.   MALARIA JOURNAL

Efficacy of fixed-dose combination artesunate-amodiaquine versus artemether-lumefantrine for uncomplicated childhood Plasmodium falciparum malaria in Democratic Republic of Congo: a randomized non-inferiority trial

(2012) Emmanuelle Espié et al.   MALARIA JOURNAL

In vivo susceptibility of Plasmodium falciparum to artesunate in Binh Phuoc Province, Vietnam

(2012) Tran Hien et al.   MALARIA JOURNAL

Molecular monitoring of plasmodium falciparum drug susceptibility at the time of the introduction of artemisinin-based combination therapy in Yaoundé, Cameroon: Implications for the future

(2012) Sandie Menard et al.   MALARIA JOURNAL

Efficacy of artemether-lumefantrine in treatment of malaria among under-fives and prevalence of drug resistance markers in Igombe-Mwanza, north-western Tanzania

(2012) Erasmus Kamugisha et al.   MALARIA JOURNAL

Evaluation of prevalence's of pfdhfr and pfdhps mutations in Angola

(2011) Filomeno Fortes et al.   MALARIA JOURNAL

Spontaneous Mutations in thePlasmodium falciparumSarcoplasmic/ Endoplasmic Reticulum Ca2+-ATPase (PfATP6) Gene among Geographically Widespread Parasite Populations Unexposed to Artemisinin-Based Combination Therapies

(2010) Kazuyuki Tanabe et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Role of pfmdr1 Amplification and Expression in Induction of Resistance to Artemisinin Derivatives in Plasmodium falciparum

(2010) M. Chavchich et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Plasmodium falciparum Isolates with Increased pfmdr1 Copy Number Circulate in West Africa

(2010) B. Witkowski et al.   ANTIMICROBIAL AGENTS AND CHEMOTHERAPY

Different mutation patterns of Plasmodium falciparum among patients in Jimma University Hospital, Ethiopia

(2010) Teferi Eshetu et al.   MALARIA JOURNAL

Geographic Structuring of the Plasmodium falciparum Sarco(endo)plasmic Reticulum Ca2+ ATPase (PfSERCA) Gene Diversity

(2010) Ronan Jambou et al.   PLoS One

Monitoring for multidrug-resistantPlasmodium falciparumisolates and analysis of pyrimethamine resistance evolution in Uige province, Angola

(2009) Michela Menegon et al.   TROPICAL MEDICINE & INTERNATIONAL HEALTH

Prevalence of pfmdr1, pfcrt, pfdhfr and pfdhps mutations associated with drug resistance, in Luanda, Angola

(2008) Paula Figueiredo et al.   MALARIA JOURNAL

Amodiaquine-artesunate vs artemether-lumefantrine for uncomplicated malaria in Ghanaian children: a randomized efficacy and safety trial with one year follow-up

(2008) George O Adjei et al.   MALARIA JOURNAL

Distinction of Plasmodium falciparum recrudescence and re-infection by MSP2 genotyping: A caution about unstandardized classification criteria

(2008) Petrica Rouse et al.   MALARIA JOURNAL

A randomized trial to monitor the efficacy and effectiveness by QT-NASBA of artemether-lumefantrine versus dihydroartemisinin-piperaquine for treatment and transmission control of uncomplicated Plasmodium falciparum malaria in western Kenya

(2008) Petra F Mens et al.   MALARIA JOURNAL